The assessment of the relationship between amniotic fluid matrix metalloproteinase-9 and zinc levels with adverse obstetric outcomes

Archives of Gynecology and Obstetrics

Volumn 290, Issue 1, 2014, Pages 59-64

  Özdamar, Özkan ^a   Gün, Ismet ^a   Müngen, Ercüment ^a   Atay, Vedat ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Adverse obstetric outcomes; Amniocentesis; MMP 9; Preterm birth; Zinc

Indexed keywords

GELATINASE B; ZINC;

ABORTION; ADULT; AMNION FLUID ANALYSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PERINATAL PERIOD; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PROGNOSIS;

ABORTION, SPONTANEOUS; ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MATRIX METALLOPROTEINASE 9; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; RETROSPECTIVE STUDIES; ZINC;

EID: 84903633443     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3179-7     Document Type: Article

References (38)

1. Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C (2010) Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 1803:3-19
2. Yonemoto H, Young CB, Ross JT et al (2006) Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta 27:669-677
3. Maymon E, Romero R, Pacora P et al (2000) Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes and intra-amniotic infection. Am J Obstet Gynecol 183:887-894
4. Xu P, Alfaidy N, Challis JR (2002) Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87:1353-1361 (Pubitemid 36121108)
5. Goldman S, Weiss A, Eyali V, Shalev E (2003) Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod 9:367-373 (Pubitemid 36748842)
6. McLaren J, Taylor DJ, Bell SC (2000) Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol 182:409-416 (Pubitemid 30127356)
7. Vadillo-Ortega F, Hernandez A, Gonzales-Avila G et al (1996) Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 174:1371-1376 (Pubitemid 26131163)
8. Matsushita S, Narumiya H, Hirata M et al (1999) Expression of matrix metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP) and transforming growth factor-β1 (TGF-β1) in human placenta during preeclampsia. Trophobl Res 13:395-406
9. Kolben M, Lopens A, Blaser J et al (1996) Proteases and their inhibitor are indicative in gestational disease. Eur J Obstet Gynaecol Reprod Biol 68:59-65 (Pubitemid 26292792)
10. Shokry M, Omran OM, Hassan HI et al (2009) Expressions of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas: preliminary findings. Exp Mol Pathol 87:219-225
11. Reister F, Kingdom JC, Ruck P et al (2006) Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR. J Perinat Med 34:272-279 (Pubitemid 44114562)
12. Merchant SJ, Crocker IP, Baker PN et al (2004) Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig 11:97-103 (Pubitemid 38229737)
13. Pustovrh C, Jawerbaum A, Sinner D et al (2002) Metalloproteinase 2 activity and modulation in the uterus from neonatal streptozotocin-induced diabetic rats during embryo implantation. Reprod Fertil Dev 14:479-485 (Pubitemid 36231131)
14. Pustovrh C, Jawerbaum A, Capobianco E et al (2005) Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta 26:339-348 (Pubitemid 40485871)
15. Lavee M, Goldman S, Daniel-Spiegel E, Shalev E (2009) Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia. Reprod Biol Endocrinol 7:85
16. Athayde N, Edwin SS, Romero R et al (1999) A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 179:1248-1253
17. Fortunato SJ, Menon R, Lombardi SJ (1997) Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol 177:731-741 (Pubitemid 27516033)
18. Kim A, Lee ES, Shin JC, Kim HY (2013) Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 34(10):873-878
19. Lawn JE, Cousens S, Zupan J (2005) 4 million neonatal deaths: when? where? why? Lancet 365:891-900
20. Hillier SL, Martius J, Krohn M et al (1988) A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 319:972
21. Maymon E, Romero R, Pacora P et al (2000) Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 183:94
22. Maymon E, Romero R, Pacora P et al (2000) Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 183:914
23. Helmig BR, Romero R, Espinoza J et al (2002) Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med 12:237
24. Goldman S, Shalev E (2006) A proposed mechanism for progesterone regulation of trophoblast MMP2 transcription independent of classical progesterone response elements on its promoter. J Exp Clin Assist Reprod 3:4
25. Hulboy DL, Rudolph LA, Matrisian LM (1997) Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3:27-45 (Pubitemid 127509422)
26. Graham CH, McCrae KR (1996) Altered expression of gelatinase and surface-associated plasminogen activator by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol 175:555-562
27. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST (2006) Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 8:1-20
28. Kai H, Ikeda H, Yasukawa H et al (1998) Peripheral blood levels of matrix metalloproteinase-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368-372 (Pubitemid 28396484)
29. Wang W, Schulze CJ, Suarez-Pinzon WL et al (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106:1543-1549
30. Pustovrh C, Jawerbaum A, Sinner D et al (2000) Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev 12:269-275 (Pubitemid 32514756)
31. Stojanovic N, Lewandowski K, Salata I et al (2010) Serum levels of matrix metalloproteinases (MMP)-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls. Gynecol Endocrinol 26:201-207
32. Johannsson E, Henriksen T, Iversen OI (2006) Increase in matrix metalloproteinases from endothelial cells exposed to umbilical cord plasma from high birth weight newborns. Am J Physiol Regul Integr Comp Physiol 292:1563-1568
33. McClure EM, Saleem S, Pasha O et al (2009) Stillbirth in developing countries: a review of causes, risk factors and prevention strategies. J Matern Fetal Neonatal Med 22:183-190
34. Brandes J, Lightman A, Ltskovitz J, Zinder O (1980) Zinc concentration in gravida's serum and amniotic fluid during normal pregnancy. Biol Neonate 38:66-70 (Pubitemid 10112964)
35. Laitinen R, Jalanko H, Kolho KL et al (1985) Zinc and alpha feto protein in amniotic fluid from early pregnancies with fetal malformations. Am J Obstet Gynecol 152:461-565
36. Wood BJ, Whyley GA, Lawrence DM (1985) Evaluation of amniotic fluid zinc levels in open neural tube defects. J Obstet Gynecol 5:215-218 (Pubitemid 15092430)
37. Kynast G, Saling E, Wagner N (1979) The relevance of zinc determination in amniotic fluid: 2nd communication: zinc in cases of high fetal risk. J Perinat Med 7:69-71
38. Mahomed K, Grant D, James DK (1993) Amniotic fluid zinc and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 52:157-161